TY - JOUR
T1 - The high-risk benign tumor
T2 - Evidence from the two-stage skin cancer model and relevance for human cancer
AU - Glick, Adam
AU - Ryscavage, Andrew
AU - Perez-Lorenzo, Rolando
AU - Hennings, Henry
AU - Yuspa, Stuart
AU - Darwiche, Nadine
PY - 2007/8
Y1 - 2007/8
N2 - Benign tumors that form following chemical initiation and promotion in the mouse skin can be grouped into two classes. The majority of papillomas do not progress to squamous cell carcinoma (SCC), and these are designated as low-risk or terminally benign papillomas. In contrast, a much smaller group forms the true precursor to the SCC, and these have a significantly higher frequency and rate of malignant conversion than the bulk of low-risk papillomas. In standard two-stage carcinogenesis studies both tumor types are present, but grossly indistinguishable. Here we describe properties and potential origins of high-risk papillomas and discuss the relevance of this model for certain human cancers with defined premalignant states.
AB - Benign tumors that form following chemical initiation and promotion in the mouse skin can be grouped into two classes. The majority of papillomas do not progress to squamous cell carcinoma (SCC), and these are designated as low-risk or terminally benign papillomas. In contrast, a much smaller group forms the true precursor to the SCC, and these have a significantly higher frequency and rate of malignant conversion than the bulk of low-risk papillomas. In standard two-stage carcinogenesis studies both tumor types are present, but grossly indistinguishable. Here we describe properties and potential origins of high-risk papillomas and discuss the relevance of this model for certain human cancers with defined premalignant states.
UR - http://www.scopus.com/inward/record.url?scp=34547863906&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547863906&partnerID=8YFLogxK
U2 - 10.1002/mc.20345
DO - 10.1002/mc.20345
M3 - Article
C2 - 17538943
AN - SCOPUS:34547863906
SN - 0899-1987
VL - 46
SP - 605
EP - 610
JO - Molecular Carcinogenesis
JF - Molecular Carcinogenesis
IS - 8
ER -